Unknown

Dataset Information

0

A common missense variant in BRCA2 predisposes to early onset breast cancer.


ABSTRACT: INTRODUCTION: Mutations in the BRCA2 gene are one of the two major causes of hereditary breast cancer. Protein-truncating mutations of BRCA2 are usually deleterious and increase the risk of breast cancer up to 80% over a lifetime. A few missense mutations in BRCA2 are believed to have a similarly high penetrance, apart from more common neutral polymorphisms. It is often difficult to classify a particular sequence variant as a mutation or a polymorphism. For a deleterious variant, one would expect a greater allele frequency in breast cancer cases than in ethnic-matched controls. In contrast, neutral polymorphic variants should be equally frequent in the two groups. METHODS: We genotyped 3,241 cases of breast cancer diagnosed at under 51 years of age, unselected for family history, from 18 hospitals throughout Poland and 2,791 ethnic-matched controls for a single BRCA2 C5972T variant. RESULTS: The variant was present in approximately 6% of the Polish population. In the study, 13 women (11 cases and two controls (OR = 4.7; p = 0.02)) were homozygous for the variant allele. The overall odds ratio for breast cancer in women with a single copy of the BRCA2 C5972T variant was 1.1 (p = 0.7); however, the effect was significant for patients diagnosed at or before age 40 (OR = 1.4; p = 0.04). We reviewed the association between the BRCA2 variant in different histologic subgroups and found the effect most pronounced in women who had ductal carcinoma in situ (DCIS) with micro-invasion (OR = 2.8; p < 0.0001). CONCLUSION: The BRCA2 C5972T allele is a common variant in Poland that increases the risk of DCIS with micro-invasion. The homozygous state is rare but increases the risk of breast cancer five-fold.

SUBMITTER: Gorski B 

PROVIDER: S-EPMC1410744 | biostudies-literature | 2005

REPOSITORIES: biostudies-literature

altmetric image

Publications

A common missense variant in BRCA2 predisposes to early onset breast cancer.

Górski Bohdan B   Narod Steven A SA   Lubinski Jan J  

Breast cancer research : BCR 20051024 6


<h4>Introduction</h4>Mutations in the BRCA2 gene are one of the two major causes of hereditary breast cancer. Protein-truncating mutations of BRCA2 are usually deleterious and increase the risk of breast cancer up to 80% over a lifetime. A few missense mutations in BRCA2 are believed to have a similarly high penetrance, apart from more common neutral polymorphisms. It is often difficult to classify a particular sequence variant as a mutation or a polymorphism. For a deleterious variant, one woul  ...[more]

Similar Datasets

| S-EPMC1735931 | biostudies-other
| S-EPMC1051149 | biostudies-other
| S-EPMC5508554 | biostudies-literature
| S-EPMC7589105 | biostudies-literature
| S-EPMC1242149 | biostudies-literature
| S-EPMC8305427 | biostudies-literature
| S-EPMC116720 | biostudies-literature
| S-EPMC3826381 | biostudies-other
| S-EPMC2965877 | biostudies-literature
| S-EPMC2867795 | biostudies-literature